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HIV-1 assembly and release are believed to occur at the plasma membrane in most host cells with the exception of
primary macrophages, for which exclusive budding at late endosomes has been reported. Here, we applied a novel
ultrastructural approach to assess HIV-1 budding in primary macrophages in an immunomarker-independent manner.
Infected macrophages were fed with BSA-gold and stained with the membrane-impermeant dye ruthenium red to
identify endosomes and the plasma membrane, respectively. Virus-filled vacuolar structures with a seemingly
intracellular localization displayed intense staining with ruthenium red, but lacked endocytosed BSA-gold, defining
them as plasma membrane. Moreover, HIV budding profiles were virtually excluded from gold-filled endosomes while
frequently being detected on ruthenium red–positive membranes. The composition of cellular marker proteins
incorporated into HIV-1 supported a plasma membrane–derived origin of the viral envelope. Thus, contrary to current
opinion, the plasma membrane is the primary site of HIV-1 budding also in infected macrophages.
Citation: Welsch S, Keppler OT, Habermann A, Allespach I, Krijnse-Locker J, et al. (2007) HIV-1 buds predominantly at the plasma membrane of primary human macrophages.
PLoS Pathog 3(3): e36. doi:10.1371/journal.ppat.0030036
Introduction
HIV-1 is an enveloped retrovirus that acquires its envelope
by budding through limiting membranes. CD4
þ T cells and
macrophages are the primary targets of HIV-1 and are
commonly used to study virus replication in tissue culture.
Infected macrophages constitute a long-lived reservoir for
HIV persistence and rebound and thus pose a major
challenge for HIV clearance from infected individuals
(reviewed in [1–3]). Recently, differences in the site of virus
assembly and budding have emerged as a major distinguish-
ing feature of HIV-1 infection in macrophages and have been
discussed as an important factor in virus persistence and
dissemination.
In HIV-1-infected primary CD4
þT cells and most cell lines,
assembly and budding occur at the plasma membrane [4–8],
possibly involving lipid rafts [6,9]. In contrast, early ultra-
structural studies implicated intracellular organelles as sites
of HIV-1 budding in infected macrophages, such as the Golgi
complex and vacuoles [10–13]. More recent immuno-electron
microscopy (EM) studies of HIV-1-infected primary human
macrophages provided strong support for the cell type–
speciﬁc intracellular budding and proposed late endosomes
(LE) and multivesicular bodies (MVB) as budding compart-
ments in these cells [14,15]. These authors reported HIV-1
budding into large intracellular vacuoles bearing markers of
LE/MVB, including tetraspanins (CD63, CD81, and CD82),
lamp-1, and MHC-II. Accordingly, extracellular infectious
virions were shown to carry tetraspanins, while being largely
devoid of most GPI-anchored and cell adhesion proteins
tested [14–17].
Topologically, HIV budding and the formation of intra-
lumenal vesicles of the MVB are similar (away from the
cytoplasm) and share the requirement for ubiquitin con-
jugation and recruitment of the cellular ESCRT-I and
ESCRT-III complexes [18]. Thus, budding of HIV-1 at LE/
MVB may be ideally suited to exploit the cellular pathway of
exosome formation. These considerations, together with the
described EM studies, led to the current view that HIV-1
assembles and buds almost exclusively from late endosomal
membranes in macrophages [14,17]. The resulting intra-
cellular accumulation of HIV-1 was proposed to be important
for pathogenesis and dissemination since HIV-1 can be
retained in an infectious state for prolonged periods of time
inside macrophages [19] and may be released in a delayed
manner similar to secretion of exosomes [20,21].
Contrary to the prevailing view of ESCRT-localization, our
recent immuno-EM analysis of uninfected and HIV-1-
infected primary human T cells and macrophages showed
that the analyzed ESCRT-proteins (HRS, TSG101, AIP1/ALIX,
and VPS4) localized to both the endosomal compartment and
the plasma membrane [22]. No signiﬁcant relocalization of
ESCRT-proteins was observed in infected cells, even when a
high producer T-cell line was analyzed [22]. Our frequent
observation of plasma membrane budding in HIV-1-infected
primary macrophages prompted us to re-assess HIV-1
budding site localization in macrophages. To this end, we
applied a novel ultrastructural approach, which is independ-
ent of immunomarker distribution, to distinguish endosomal
structures from the plasma membrane. Our results reveal that
the plasma membrane is the predominant site of HIV-1
budding also in primary macrophages and suggest a general
pathway of HIV-1 morphogenesis.
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EM Analysis of HIV-1-Infected Primary Human
Macrophages Reveals Viral Budding at Vacuolar Structures
and at the Plasma Membrane
We revisited HIV-1 assembly and budding in primary
human monocyte-derived macrophages (MDM), which had
been used in previous studies to demonstrate HIV-1
accumulation within intracellular compartments [10–15].
MDM cultures infected with either of the two macrophage-
tropic HIV-1 strains Ba-L or YU-2 showed largely similar
replication kinetics (unpublished data). Cells were ﬁxed for
EM at the peak of virus release, usually around 12–17 d after
infection, and either embedded in Epon before sectioning or
processed for cryo-sections followed by immunolabeling.
Accumulation of mature HIV-1 particles with typical cone-
shaped capsid morphology in large, seemingly intracellular
vacuolar structures was readily detected in HIV-1 Ba-L-
(Figure 1A and 1B) or YU-2- (not shown) infected cells. While
virus-ﬁlled vacuolar structures were often observed, detection
of typical HIV-1 budding structures was much less common.
Importantly, early (Figure 1A and 1C) and late (Figure 1B)
budding proﬁles were detected on the plasma membrane
(Figure 1B and 1C; open arrows), as well as on membranes
that appeared to be intracellular on thin sections (Figure 1A;
open arrow). This result was independent of the method of
monocyte enrichment or cultivation of MDM (unpublished
data). Furthermore, infected and uninfected MDM revealed a
complex surface architecture with numerous protrusions and
cross-sectioned invaginations suggesting that some appa-
rently intracellular structures may be connected to the cell
surface.
Immuno-EM using antiserum against the HIV-1 capsid
protein readily identiﬁed HIV-1 particles in large vacuolar
structures with an apparent intracellular localization, both
for strain YU-2 (Figure 1D) and Ba-L (Figure 1E and 1F). The
limiting membrane of these structures was sometimes
connected to the extracellular space, indicating that they
represented deep plasma membrane invaginations (Figure
1F). Furthermore, virus particles were frequently detected in
the extracellular space (Figure 1G). Many virus-ﬁlled vacuolar
structures contained membrane protrusions similar to the
cell surface (see below), and their limiting membrane
sometimes displayed structures resembling clathrin-coated
pits (Figure 1H and 1I). HIV-1 budding proﬁles were detected
on the limiting membrane of vacuolar structures (Figure 1H)
and on the plasma membrane (Figure 1G, 1J, and 1K).
Budding proﬁles were often next to structures resembling
clathrin-coated pits (Figure 1H, 1J, and 1K, arrows), even
when budding occurred into seemingly intracellular va-
cuoles. The observation of signiﬁcant plasma membrane
budding and of hallmarks of the plasma membrane on the
limiting membranes of seemingly intracellular vacuoles
prompted us to characterize the origin of these vacuolar
structures in more detail. Sections of YU-2- and Ba-L-
infected MDM were morphologically indistinguishable, and
we therefore used Ba-L-infected MDM throughout the
remainder of the study.
An Immunomarker-Independent Approach to
Discriminate Plasma Membrane from Endocytic
Compartments
Previous studies of HIV-1 morphogenesis in infected cells
relied on immunolabeling of cellular proteins to identify
membrane compartments. To allow an immunomarker-
independent identiﬁcation of the plasma membrane and
endosomes, we combined two established EM methods in a
novel ultrastructural approach. This involved labeling of
endocytic compartments by internalizing BSA-gold followed
by staining of the plasma membrane with ruthenium red (RR)
during ﬁxation. RR is a membrane-impermeant dye, which
binds to carbohydrate moieties on the cell surface [23,24].
Because of its small size, RR can readily penetrate into
membrane invaginations [25], while ﬁxation at 4 8C prevents
its internalization. Upon post-ﬁxation, RR forms an electron-
dense precipitate detectable on Epon-sections, and this
method has been used to study HIV-1 entry in macrophages
[26]. Our previous experiments had shown that over 75% of
all endosomal structures of primary human macrophages,
including LE, were ﬁlled with BSA-gold after 2 h of internal-
ization [22]. Accordingly, the combination of BSA-gold
uptake and RR staining should unequivocally identify
membrane structures as being of endosomal or plasma
membrane origin. This was ﬁrst tested on uninfected MDM
to validate our approach (Figure 2).
Figure 2A shows MDM morphology at low magniﬁcation;
the smooth cell surface facing to the left was previously
attached to the culture dish and is therefore poorly stained
with RR. The complex upper surface is facing to the right,
with many ﬁnger-like surface protrusions clearly stained with
RR (Figure 2B). Two neighboring cells form a tight-ﬁtting
contact zone with interdigitating membranes (Figure 2A,
arrows). Importantly, the limiting membranes of large,
seemingly intracellular vacuolar structures that were hetero-
geneous in size and shape were also stained with RR, thus
deﬁning them as plasma membrane–derived (Figure 2A–2F).
These structures generally had no apparent connection to the
cell surface in the plane of the section and were often found
deep inside the cell (Figure 2B and 2C). No RR labeling was
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Author Summary
Macrophages are one of the major target cells for HIV-1 infection
and play an important role in viral pathogenesis. Previous studies
indicated that the pathway of HIV-1 particle morphogenesis is
distinct in primary human macrophages, and this has been
suggested to play a role in viral persistence. Early reports indicated
that HIV-1 accumulates within apparently intracellular vacuolar
structures, which were later identified as being of late endosomal
origin. Endosomes were therefore suggested to comprise the
budding and storage compartment for HIV-1 in primary human
macrophages, from which infectious virus can be released in a
regulated manner. In the present study, we show that HIV-1
budding occurs predominantly at the plasma membrane also in
primary human macrophages. Using electron microscopy, we
observed that the cell surface of macrophages displays an
unexpectedly complex morphology with many protrusions and
deep invaginations. HIV-1 budding occurs primarily at these
invaginations that are clearly connected to the cell surface and do
not belong to the endocytic compartment. Mature virus particles
can remain trapped within such invaginations giving the appear-
ance of an intracellular budding compartment. These results
suggest a general pathway of HIV-1 morphogenesis with the
plasma membrane as viral budding site.observed on the nuclear membrane and on membranes of the
endoplasmic reticulum, Golgi complex, or mitochondria. RR-
positive vacuoles never contained BSA-gold and BSA-gold-
labeled endosomes were always devoid of RR (Figure 2C–2F),
conﬁrming the speciﬁcity of our approach. BSA-gold-labeled
endosomes were generally more electron-dense, often round
or oval-shaped, and signiﬁcantly smaller than the RR-stained
vacuoles.
The RR-positive structures often enclosed stacked mem-
branes resembling plasma membrane protrusions (Figure 2D
and 2E). Morphologically identical RR-negative structures
were also observed, sometimes next to RR-positive structures
(Figure 2E). They were never ﬁlled with BSA-gold (e.g., Figure
2E) and are thus unlikely to be of endocytic origin. Their
failure to stain with RR suggested that they are not directly
connected to the cell surface, while their morphology
strongly suggested a plasma membrane origin. Lack of
staining may be explained by inaccessibility to the stain,
however, as supported by inefﬁcient staining of the cell
surface attached to the substrate (Figure 2A).
Figure 1. A Gallery of Primary Human MDM Infected with HIV-1 Strains YU-2 and Ba-L
Cells were infected with HIV-1 strain Ba-L (A–C, E, F, and H–J) or YU-2 (D, G, and K).
(A–C) Shows plastic-embedded sections displaying extra- and seemingly intracellular virions and budding profiles (open arrows).
(D–K) Thawed cryo-sections were labeled with anti-capsid followed by 10 nm (D–G, J, and K) or 5 nm (H and I) protein A gold.
(D and E) Labeled virions accumulated inside vacuolar structures.
(F) Labeled virions in a plasma membrane invagination that is directly connected to the extracellular space.
(G) A virus-budding profile (open arrow) and several virus particles on the plasma membrane.
(H) A virus-budding profile (open arrow) next to a structure resembling a clathrin-coated pit (arrow) inside a vacuolar structure.
(I) A virus-containing vacuole with a structure resembling a clathrin-coated pit (arrow).
(J and K) Virus-budding profiles (open arrows) next to structures resembling clathrin-coated pits (arrows) on the cell surface. PM, plasma membrane. Bar,
200 nm.
doi:10.1371/journal.ppat.0030036.g001
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in Plasma Membrane–Derived Structures in MDM
Next, this approach was used to identify the membranes of
HIV-1-containing compartments and of viral budding sites in
MDM. Cells infected with HIV-1 Ba-L were fed with BSA-gold
followed by RR staining at the peak of virus production
(Figure 3A). Infected cells displayed a complex surface
organization similar to uninfected MDM with many seemingly
intracellular vacuoles (Figure 3B, arrows) containing mature
HIV-1 with cone-shaped cores. Importantly, the limiting
membrane of many of these vacuoles and the surface of the
enclosed virions were strongly RR-positive, similar to the cell
surface and extracellular virions (Figure 3B–3I). Identical
virus-ﬁlled structures were observed in cells that had not
been starved and ﬁlled with BSA-gold prior to ﬁxation,
clearly showing that this phenotype was not affected by the
pre-treatment (unpublished data). The RR-positive virus-
harboring structures contained protrusions reminiscent of
the plasma membrane (Figure 3C), sometimes displayed
structures resembling clathrin-coated pits (Figure 3E and
3F), and were never labeled with BSA-gold, also indicating
that they were cell surface–derived. Figure 3D shows a large
RR-positive vacuolar structure with many protrusions and
numerous mature HIV-1 particles that is directly connected
to the cell surface. RR-positive early and late HIV-1 budding
proﬁles were observed at the cell surface (Figure 3H) and on
vacuolar structures (Figure 3I), conﬁrming that virus assembly
and release did occur on plasma membrane invaginations
that appeared intracellular in thin sections.
Similar to the observations with uninfected MDM, a subset
of virus-harboring vacuolar structures was not stained with
RR, while the morphology of these structures was indistin-
guishable from the corresponding RR-positive compartment
(Figure 3J and 3K). HIV-1 budding sites were also observed on
such RR-negative membranes (Figure 3J and 3K). These
structures were always devoid of BSA-gold and thus did not
belong to the endocytic pathway. Gold-ﬁlled endosomes were
often detected in the vicinity of HIV-1-containing vacuoles
(Figure 3D, 3E, and 3K) and appeared signiﬁcantly smaller
than virus-ﬁlled vacuoles. This was quantiﬁed by measuring
Figure 2. RR Staining of Uninfected MDM Reveals a Complex Plasma Membrane Organization
MDM were fed with BSA-gold and fixed in the presence of RR.
(A) A cell profile at low magnification contacting a neighboring cell. The smooth left side was previously attached to the substrate (indicated as
‘‘bottom’’); the right side displaying many RR-positive protrusions is the side facing the extracellular medium (‘‘top’’). Seemingly intracellular structures
also appear RR-positive. At the tight-fitting contact zones between two cells (arrows) the stain appears more electron-dense than on single lipid
bilayers.
(B) Higher magnification of the boxed area in (A) showing the collection of vacuolar-like invaginations stained with RR.
(C) Higher magnification of the boxed area in (B) showing a RR-positive structure next to a BSA-gold-filled endosome (arrowhead).
(D) Comparison of RR-positive cell surface protrusions and similar RR-positive protrusions, which appeared intracellular in this section. Arrowheads
indicate gold-filled endosomes. The inset in (D) shows an enlargement of a BSA-gold-filled endosome in the boxed area.
(E) Two identical looking structures with stacked protrusions; in the upper one the membranes are not RR-stained, indicating that not all vacuolar
structures are accessible to the stain.
(F) A collection of BSA-gold-filled endosomes (arrowheads) next to RR-stained vacuolar structures to emphasize the differences in size and morphology.
The inset in (F) shows an enlargement of a BSA-gold-filled endosome in the boxed area. Nu, nucleus. Bars, 2 lm (A and B) and 500 nm (C–F).
doi:10.1371/journal.ppat.0030036.g002
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HIV-1 Budding in Human MacrophagesFigure 3. HIV-1 Buds and Accumulates in RR-Stained Domains
(A) Flow diagram of macrophage differentiation, infection, and processing for EM. CA, capsid protein.
(B) Low magnification profile of an infected MDM displaying RR stain on the cell surface and on seemingly intracellular plasma membrane invaginations
(arrows). Note that the bottom surface (indicated as ‘‘bottom’’) that was previously attached to the substrate is not RR-stained, whereas the top surface
is. The inset shows a mature virus particle on the tip of a finger-like plasma membrane protrusion.
(C) Collection of RR-stained protrusions with RR-stained mature virus particles.
(D) Large cell-surface invagination that is directly connected to the RR-stained cell surface and contains numerous RR-stained virions. The inset shows a
multivesicular BSA-gold-filled endosome inside the same cell.
(E and F) RR-stained vacuole-like structures harboring virus particles and displaying structures resembling clathrin-coated pits (small arrows).
Arrowheads in (E) indicate gold-filled endosomes that are not RR-stained and significantly smaller than the virus-filled structures.
(G) RR-stained virus particles accumulating between the RR-stained plasma membranes of two neighboring cells; arrowheads, BSA-gold-filled
endosomes. The inset in (G) shows an enlargement of a BSA-gold-filled endosome in the boxed area.
(H–K) Virus-budding profiles (open arrows) (H) on the RR-stained cell surface and (I) on a RR-stained cell surface invagination.
(J) Early virus bud on the tip of a finger-like protrusion in a vacuolar structure devoid of RR and BSA-gold.
(K) Late virus buds on RR-negative membranes next to BSA-gold-filled endosomes (arrowheads). Nu, nucleus; PM, plasma membrane. Bars, 2 lm (B–D)
and 500 nm (E–K).
doi:10.1371/journal.ppat.0030036.g003
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HIV-1 Budding in Human Macrophagesthe surface area of virus-ﬁlled vacuoles and endosomes (Table
1). The vacuolar structures covered 1–3.1 lm
2, while endo-
somes had an average size of 0.08 lm
2 and were thus ten to 40
times smaller.
For a quantitative assessment of virus-speciﬁc structures,
their localization in infected MDM from three different
donors was attributed to one of three compartments depend-
ing on the presence or absence of RR and/or BSA-gold. Over
94% of HIV-1-speciﬁc structures were detected in compart-
ments devoid of internalized gold. These structures were
mostly stained with RR in the case of two donors (60% and
80% of all structures, respectively; Figure 4A, donors 1 and 3),
while the majority of virus accumulated in RR-negative (and
BSA-gold-negative) structures in the case of donor 2.
Accumulation of HIV-1 in a certain compartment does not
necessarily imply that budding occurs from this compart-
ment, and the localization of viral budding sites was therefore
also quantiﬁed. The absolute number of budding proﬁles was
relatively small since 91%–97% of all HIV-1-speciﬁc struc-
tures observed corresponded to free virus particles. Impor-
tantly, quantiﬁcation of budding proﬁles revealed that 98%–
100% localized to BSA-gold-negative structures with the
relative distribution between RR-positive (40%–60%) and
RR-negative budding proﬁles being similar to that observed
for free viruses (Figure 4B).
Distribution of Cellular Marker Proteins Supports a Plasma
Membrane Origin of the Viral Envelope
Although the RR-negative virus-containing structures were
morphologically indistinguishable from the RR-positive ones
and never contained BSA-gold, they could have represented a
population of endosomes that is not part of the active
endocytic pathway and therefore inaccessible to the endo-
cytic tracer. The tetraspanins CD63, CD81, and CD82 and the
lysosomal membrane protein lamp-1 were previously shown
to localize to endosomal compartments and to be incorpo-
rated into the viral envelope of macrophage-derived HIV-1
particles [14,27–29]. Since the presence of these membrane
proteins in the HIV-1 envelope has been taken as important
evidence that HIV-1 buds into endosomes in MDM [14], we
tested their localization in infected MDM and included CD44
as a plasma membrane marker [30].
As expected, CD63 was predominantly found on mem-
branes of BSA-gold-ﬁlled endosomes (Figure 5A). Signiﬁcant
labeling for this marker was also detected on the plasma
membrane (Figure 5B) as reported previously [17,31]. CD63
labeling at the plasma membrane was uneven with areas of
higher and lower density (unpublished data). The tetraspa-
nins CD81 and CD82 and the lysosomal protein lamp-1
exhibited a similar labeling pattern as CD63, albeit with a
lower labeling efﬁciency (Figure S1).
Consistent with the cell surface localization of this marker,
CD63-positive budding proﬁles were observed at the plasma
membrane (Figure 5C). Extracellular virions (unpublished
data), particles inside vacuolar structures, and the limiting
membranes of these structures were positive for CD63 (Figure
5D and 5E), and, to a lesser extent, lamp-1, CD81, and CD82
(Figure S1) as previously reported [14]. For each of these
markers, labeling of the limiting membrane was similar on all
virus-containing structures, suggesting that they do not
segregate into separate classes. Importantly, CD44, which
localized almost exclusively to the plasma membrane and was
absent from BSA-gold-ﬁlled endosomes (Figure 5F–5H), was
also readily detected at budding sites (Figure 5G) and
efﬁciently incorporated into HIV-1 particles (Figure 5F and
5H).
Quantitative analysis of the labeling densities of CD63
(Figures 6A and S2) and CD44 (Figure 6B) revealed that they
were virtually identical on the plasma membrane and on the
limiting membrane of virus-ﬁlled vacuolar structures, sup-
porting a cell surface origin of the latter. The labeling density
of CD63 in uninfected and infected MDM was 2- to 3-fold
higher on endosomes than at the plasma membrane, and the
labeling density on virions was intermediate between the two
(Figure 6A). In contrast, CD44 was almost exclusively found at
the plasma membrane and virus-ﬁlled vacuolar membranes
and was excluded from gold-ﬁlled endosomes (Figure 6B).
The CD44 labeling density was identical on the plasma
membrane, the limiting membranes of virus-ﬁlled vacuolar
structures, and the membranes of enclosed HIV-1 particles
(Figure 6B), supporting the plasma membrane origin of the
particle membrane.
To correlate the immuno-EM data with the membrane
composition of infectious HIV-1 particles derived from
MDM, we immunoprecipitated MDM-derived virus with
monoclonal antibodies to CD63, CD44, or control antibodies,
respectively, as previously described [14,32]. Precipitation
with anti-CD63 reduced infectivity by ;40% (Figure 6C), and
this was similar for virus derived from MDM of different
donors (Figure S2). These data are consistent with previous
studies showing that CD63 is incorporated into infectious
HIV-1 from MDM [14,16]. An even stronger titer reduction
Table 1. Average Profile Area of Virus-Filled Vacuoles and Gold-Filled Endosomes in Primary Human Macrophages
Cellular Structure Vacuoles BSA-Gold -Positive Endosomes
a
Origin Average







Average profile area (lm
2) 2.15 3.15 1.12 0.98 0.08 0.09 0.05
SE
b 0.64 1.38 0.40 0.43 0.01 0.02 0.01
aClearly identifiable endosomal profiles, abundantly filled with BSA-gold were considered.
bSE, standard error of the mean.
cThe average profile area of virus-filled vacuoles is based on the images of Figure 1A and 1B, 2A, and 3A–3C in the publication by Raposo et al. [15]; the Figure 3A–3D, 4A and 4B, 5A, 6A–
6C, and 7A in Pelchen-Matthews et al. [14]. These two studies used cryo-sections of infected macrophages only. The values D1 to D3 therefore represent the average profile area of virus-
filled vacuoles or gold-filled endosomes estimated on cryo-sections of infected macrophages from donor 1 to 3 (representing the same donors as in Figure 4). The profile area was
estimated using standard stereological methods.
d12–15 vacuoles and 20–25 gold-filled endosomes were considered per donor.
doi:10.1371/journal.ppat.0030036.t001
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HIV-1 Budding in Human Macrophageswas observed when virus was precipitated with antibodies
against the plasma membrane marker CD44 (;80%, Figures
6C and S2). Collectively, these results support the conclusion
of predominant plasma membrane budding of HIV-1 in
primary human macrophages.
Discussion
The current view of HIV-1 morphogenesis distinguishes
two fundamentally different pathways of virus release. This
implies differences in targeting and membrane interaction of
viral components, depending on the host cell. HIV-1 budding
is readily detected by EM at the plasma membrane of T-
lymphocytes, which are morphologically small and charac-
terized by a large nucleus and a small cytoplasmic compart-
ment. In infected macrophages, on the other hand, HIV-1 has
long been reported to accumulate within large vacuoles [10–
13], recently described as being of endosomal origin
[14,15,21]. This assignment was based on immunolocalization
of cellular proteins in combination with the intuitively
appealing concept of common use of the ESCRT-machinery
for MVB formation and HIV release at the same site. Here, we
report that the seemingly intracellular virus-ﬁlled vacuoles
are largely continuous with the plasma membrane and
conclude that HIV-1 budding occurs predominantly at the
plasma membrane also in macrophages. This is mainly based
on the following observations: (i) the frequent detection of
HIV-1 budding sites at the plasma membrane, (ii) the
predominant HIV-1 budding and accumulation in RR-
positive structures, (iii) the virtual exclusion of budding sites
and HIV-1 particles from BSA-gold-ﬁlled endosomes, (iv) the
size of virus-ﬁlled compartments being much larger than that
of endosomes, and (v) the composition and labeling density of
cellular proteins in the viral envelope supporting its plasma
membrane origin. It is important to note that the sizes of
virus-ﬁlled structures in this and previous studies were very
similar (Table 1; [14,15]), implying that these compartments
are the same. Thus, our experimental ﬁndings applying
previously used techniques are entirely consistent with prior
reports, while our interpretation—largely based on an
immunomarker-independent approach—is fundamentally
different.
The incorporation of speciﬁc cellular membrane proteins
into the HIV-1 envelope has been taken as evidence for the
origin of the viral membrane [32,33]. This interpretation
suffers from the fact that HIV-1 produced from T cells—
where the virus buds through the plasma membrane—carries
the same marker proteins (reviewed in [34]). The distribution
of cellular proteins is generally not exclusive to a single
membrane system, however, and CD63 and other tetraspa-
nins, while clearly enriched at LE, are also detected at the
plasma membrane [17,35]. We found a 2- to 3-fold difference
in CD63 density when comparing the endosomal and plasma
membrane, with an uneven distribution of CD63 in different
regions of the latter. This observation is consistent with two
recent studies reporting the presence of tetraspanin-enriched
microdomains in the plasma membrane of T cells and cell
lines, from which HIV-1 was suggested to bud preferentially
[31,36]. We observed a higher labeling density for CD63 in the
HIV-1 membrane compared to the plasma membrane or
membranes of virus-ﬁlled structures, consistent with HIV-1
budding from CD63-rich plasma membrane microdomains
also in MDM. Plasma membrane budding was supported by
the efﬁcient labeling of HIV-1 buds and particles with anti-
CD44, which localized almost exclusively to the plasma
membrane. Furthermore, infectious virus was almost quanti-
tatively precipitated by anti-CD44. This had also been
observed in previous studies, where anti-CD44 precipitated
.95% of infectious HIV-1 [16,37]. Thus, the collective studies
on incorporation of cellular membrane proteins into HIV-1
support a plasma membrane origin of the viral envelope,
independent of the infected host cell.
To deﬁne the budding membrane of HIV-1 in infected
macrophages in an immunomarker-independent manner, we
combined two established EM methods in a novel ultra-
structural approach. Endosomes were functionally labeled
with BSA-gold and the plasma membrane was stained with
Figure 4. Quantification of Membrane Structures Where HIV-1 Accumu-
lates and Buds
Three types of cellular membranes, either surrounding free virus or
displaying budding sites, were considered: (i) RR-positive without
internalized BSA-gold (RR
þ, BSA-gold
 ), (ii) RR-negative without BSA-
gold (RR
 , BSA-gold
 ), and (iii) RR-negative with BSA-gold (RR
 , BSA-
gold
þ). No RR-positive, BSA-gold-positive structures were observed.
(A) Numbers of viral structures (sum of free virus particles and budding
profiles) seen on the three types of membrane structures in infected
MDM prepared from three blood donors (designated 1–3). Free virus
included mature virions with a typical conical core and immature
particles displaying an electron dense Gag shell. Budding sites include
‘‘late buds’’ consisting of spherical profiles that are connected to a
membrane via a stalk (see, for instance, Figure 3K and ‘‘early buds’’) and
half-moon-shaped membrane profiles with an electron-dense Gag shell
on their concave side (see, for instance, Figure 3H).
(B) Distribution of budding profiles over the same three membrane
structures and of the same three donors as in (A).
doi:10.1371/journal.ppat.0030036.g004
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HIV-1 Budding in Human Macrophagesthe membrane-impermeant dye RR [23,24,38]. Importantly,
RR staining and BSA-gold never colocalized to the same
compartment and no RR staining of internal organelles was
detected, validating our approach. HIV-1 commonly accu-
mulated in large, seemingly intracellular RR-positive struc-
tures, which were thus deﬁned as plasma membrane
invaginations. Although budding structures were much more
rare, they were also observed at the RR-stained limiting
membrane of such seemingly intracellular invaginations (and
not on gold-ﬁlled endosomes), and the enclosed virus was
stained with RR as well. The RR-positive compartment
contained the majority of HIV-1 particles and budding sites,
but they were also observed at RR-negative structures. We
suggest that these virus-ﬁlled structures were similar, if not
identical, to RR-stained invaginations and were also derived
from the plasma membrane, but have not been accessible to
RR for technical reasons. RR staining was poor for the
substrate-adherent plasma membrane of MDM, and this
would thus be expected for structures connecting to this
surface as well. Notably, the size and morphology of RR-
positive and RR-negative structures was identical, the latter
also displayed occasional structures resembling clathrin-
coated pits and membrane protrusions, and virus-ﬁlled
structures were consistently CD44-positive. Furthermore,
the density of both CD63 and CD44 was identical for plasma
membrane and virus-ﬁlled vacuolar structures as would be
expected if they represent the same compartment. Finally,
labeling of the limiting membrane with antibodies against
Figure 5. Localization of CD63 and CD44 in HIV-1-Infected MDM
HIV-1 strain Ba-L-infected MDM were fed with 10 nm BSA-gold (except in G) for 2 h before fixing. Thawed cryo-sections were single-labeled with anti-
CD63 (A and B, 15 nm gold) or anti-CD44 (F, 15 nm gold); or double-labeled with anti-capsid (C–E, G, and H, 5 nm gold) and anti-CD63 (C–E, 15 nm
gold); or anti-CD44 (G, 10 nm gold and H, 15 nm gold).
(A) CD63 (arrows) on endosomes efficiently filled with BSA-gold and on tubular vesicular membranes nearby.
(B) CD63 (arrows) on plasma membrane protrusions of two adjacent cells.
(C) A virus-budding profile labeled for anti-capsid (5 nm gold, open arrows) and anti-CD63 (15 nm gold) at the plasma membrane.
(D and E) Virions inside vacuolar structures, labeled with anti-capsid (5 nm), are significantly labeled with anti-CD63. The inset in (D) shows the
enlargement of double-labeled virions in the boxed area of (D). CD63 also localizes to BSA-gold-filled endosomes (arrowheads in E). Note that the virus-
filled structure in (E) is devoid of 10 nm BSA-gold and displays a structure that resembles a clathrin-coated pit (small arrow).
(F) CD44 at the plasma membrane.
(G and H) CD44 on virions and on a budding profile (open arrow in G). The inset in (H) is an enlargement of the boxed area in (H) and shows several
double-labeled virions inside a vacuolar structure.
Note that CD44 is excluded from BSA-gold-filled endosomes (arrowheads in F and H). PM, plasma membrane. Bars, 200 nm.
doi:10.1371/journal.ppat.0030036.g005
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HIV-1 Budding in Human Macrophagestetraspanins (CD63, CD81, and CD82) was consistent for all
virus-containing structures, indicating that these structures
comprise a homogenous population.
A direct connection of the virus-ﬁlled compartment to the
cell surface within the plane of the section was only detected
in rare cases, which may not be surprising given the complex
three-dimensional architecture of the MDM plasma mem-
brane. Images of virus-ﬁlled structures in direct membrane
continuity with the cell surface have also been published
previously [15], but were interpreted as exocytic vacuoles
releasing virus budded at endosomal membranes. We
consider this interpretation unlikely because virus-ﬁlled
structures were devoid of BSA-gold, displayed features of
the plasma membrane (see above), and were CD44-positive.
Moreover, the large number of RR-positive structures would
require a major part of the endomembrane system to be
involved in exocytosis at any time, which cannot be
reconciled with the main function of macrophages as
phagocytic scavengers.
Our conclusion of plasma membrane budding of HIV-1 in
primary human macrophages is in complete agreement with a
report published while this work was under review [39]. These
authors based their conclusion on kinetic analyses of Gag
trafﬁcking and virus release in the presence of various
inhibitors and on targeting mutants of HIV-1 Gag and
suggested that the intracellular pool of HIV-1 in macrophages
may be due to phagocytosis of virions after their initial
release at the plasma membrane [39]. Our ultrastructural
analysis of primary human macrophages incubated overnight
with large amounts of HIV-1 revealed virtually no viral
particles in the endosomal compartment, however, arguing
against this interpretation (unpublished data). The experi-
ments presented here showed that uninfected and HIV-1-
infected macrophages acquire a complex plasma membrane
organization with many protrusions and tightly interdigitated
cell contact zones as well as deep invaginations that on
sections resemble large intracellular vacuoles. These struc-
tures enlarge the surface of the plasma membrane and may be
physiologically relevant to sense the environment and to
engulf particles to be destroyed. It is tempting to speculate
that these highly convoluted parts of the plasma membrane
may be different in nature compared to the cell surface that
directly faces the growth medium. HIV-1 buds at this complex
surface membrane, and infectious virions may be trapped in
membrane pockets and accumulate there. Since infected
macrophages are known to persist for months, these
infectious virions could be released over extended periods
of time, consistent with a recent report of prolonged storage
of infectious HIV-1 in MDM [19]. Although this scenario is
similar to the delayed exosome-release hypothesis [20], it is
likely that the regulation of virus storage and release underlie
an entirely different mechanism. Most importantly, however,
our study suggests a universal morphogenesis pathway for
HIV-1 with virus release occurring predominantly at the
plasma membrane, independent of the host cell.
Materials and Methods
Reagents and antibodies. All tissue culture reagents were from
GIBCO BRL (http://www.invitrogen.com), unless otherwise indicated.
EM chemicals were from EMS (http://www.emsdiasum.com) and
Uranyl acetate was from Fluka (http://www.sigmaaldrich.com). All
Epon embedding solutions, propylene oxide, and RR were from Serva
Figure 6. Quantification of Labeling Density and Virus Precipitation by
Antibodies to Cellular Membrane Proteins
(A and B) Labeling densities for CD63 and CD44 were quantified on late
endosomes (identified by the presence of internalized gold and by their
morphology) and the cell surface (only clearly identifiable plasma
membrane was considered) of uninfected or infected MDM. In infected
cells, the labeling densities on viral particles (‘‘virus’’) and on the limiting
membrane of virus-containing vacuolar structures (‘‘vacuolar mem-
brane’’) was also included. Values represent the average from two
independent labeling experiments and two different grids per experi-
ment. The quantification was performed for MDM from the same donor 1
as in Figure 4; the results for the two other donors are shown in Figure
S2. Error bars denote standard error.
(C) Remaining infectivity in supernatants of HIV-infected MDM after virus
immunoprecipitation with anti-CD63 or anti-CD44, analyzed by infection
of a HIV-1-permissive reporter cell line. Values obtained after precip-
itation with isotype control antibodies were set at 100%. Virus was
obtained from MDM culture supernatant of the same donor as in (A and
B). Error bars denote standard deviation.
doi:10.1371/journal.ppat.0030036.g006
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HIV-1 Budding in Human Macrophages(http://www.serva.de). Bovine Albumine Fraction V (Biomol, http://
www.biomol.com) coupled to 10 nm gold was prepared as described
[40]. Anti-CD63 mAb 1B5 (used for immuno-EM) was a kind gift from
M. Marsh, anti-CD63 mAb FC5.01 was from Zymed (Invitrogen, http://
www.invitrogen.com). Anti-lamp-1 mAb H4A3 was from DSHB
(http://www.uiowa.edu/;dshbwww/info.html), anti-CD44 mAb F10-
44-2 from Chemicon (http://www.chemicon.com), and rabbit-anti-
mouse IgG from ICN Biomedicals (http://www.mpbio.com). Anti-
CD81 mAB M38 and anti-CD82 mAB M104 were kind gifts from F.
Berditchevski. Anti-nPKCh IgG2a (E-7, purchased from Santa Cruz
Biotechnology, http://www.scbt.com) was used as isotype control.
Polyclonal rabbit antiserum against the HIV-1 capsid protein was
raised against bacterially expressed and puriﬁed protein.
Cells, viruses, and infections. Cultures of primary human MDM
were routinely prepared from Ficoll gradient-puriﬁed peripheral
blood mononuclear cells isolated from single, healthy, HIV-1-
seronegative blood donors (DRK Blutspendezentrale, Mannheim,
Germany) by adherence and were differentiated in culture for 6–8 d
as described [22], in the presence or absence of recombinant human
M-CSF (5 ng/mL; R & D Systems, http://www.rndsystems.com).
Alternatively, MDM were differentiated from CD14 magnetic bead-
selected monocytes from peripheral blood mononuclear cells
according to the manufacturer’s protocol (Miltenyi Biotec, http://
www.miltenyibiotec.com). Details regarding MDM cultivation, infec-
tion with the macrophage-tropic HIV-1 strains YU-2 [41] or Ba-L
(purchased from Advanced Biotechnologies, http://www.abionline.-
com), BSA-gold feeding, and RR staining are provided in Figure 3A.
BSA-gold feeding and RR stain. Primary human MDM were either
left untreated or starved overnight in DMEM with 5% fetal calf serum
(DMEM/5%), followed by an additional 2-h starvation in serum-free
DMEM prior to BSA-gold feeding. Cells were either washed three
times with ice-cold 20 mM EDTA/PBS and ﬁxed directly or incubated
for 2 h with BSA-gold (ﬁnal OD520 ¼ 10) in DMEM/10% containing
10% human AB-positive serum at 37 8C, conditions that have been
shown to ﬁll at least 75% of all endocytic compartments in MDM
including late endosomes and lysosomes [22,29]. BSA-gold-ﬁlled cells
were placed on ice and washed as above to remove excess BSA-gold
and to partially detach the cells from the culture dish prior to
ﬁxation. All cells were ﬁxed with 2.5% glutaraldehyde in 0.1 M ice-
cold Na-Cacodylate buffer (pH 7.2) containing 0.5 mg/ml RR for 1 h,
during which time cells were allowed to warm up to room temper-
ature. Cells were then washed with 0.1 M Na-Cacodylate buffer (pH
7.2), post-ﬁxed with 2% OsO4 in the same buffer containing 0.5 mg/
ml RR for 1 h at room temperature before routine embedding in
Epon as described [42].
Immuno-EM. Cryo-sections of ﬁxed cells were prepared as
described [43] and immunolabeled as before [42,44]. Sections were
examined with a Zeiss EM10 (http://www.zeiss.com). The quantiﬁca-
tion of CD63 and CD44 labeling density was carried out and
calculated essentially as described [22,42]. Values represent counts
from at least two different grids and two independent labeling
experiments per cell donor.
HIV-1 immunoprecipitation assay. Immunoprecipitation of HIV-1
from culture medium of HIV-1 Ba-L-infected MDM was essentially
done as described [14,32] using anti-CD63 (FC5.01, Zymed), anti-
CD44 (F10-44-2, Chemicon), or an IgG2a isotype control antibody (all
at 5 lg/ml). After precipitation, the supernatants were analyzed for
remaining unprecipitated infectious virus in a standard reporter cell
assay as described [45].
Supporting Information
Figure S1. Localization of Lamp-1 and Tetraspanins CD81 and CD82
and Incorporation into Virus Particles at Low Levels in HIV-1-
Infected MDM
Thawed cryo-sections of HIV-1 strain Ba-L-infected MDM, fed with
10 nm BSA-gold for 2 h prior to ﬁxation, were either labeled with
anti-CD81 (B and F) or CD82 (A, C, and G) and 15 nm gold (A–C, F,
and G) or double-labeled with anti-lamp-1 (15 nm gold) and anti-
capsid (5 nm gold, D and E).
(A) CD82 (arrows) localizes to BSA-gold-ﬁlled endosomes (arrow-
heads) at low levels.
(B and C) CD81 and CD82 (arrows) both localize to the plasma
membrane.
(D and E) Lamp-1 (arrows) localizes to BSA-gold-ﬁlled endosomes
(arrowheads in E) and is incorporated at low amounts into virus
particles accumulating in vacuolar structures.
(F and G) Incorporation of CD81 (arrows in F) and CD82 (arrows in
G) at low levels into virus particles that accumulate inside vacuolar
structures. The arrowhead in (G) points at a BSA-gold-ﬁlled endo-
some.
Note that the vacuolar structures in (D–G) are devoid of 10 nm BSA-
gold. Bars, 200 nm.
Found at doi:10.1371/journal.ppat.0030036.sg001 (15 MB TIF).
Figure S2. Labeling Densities of CD63 and Virus Precipitation with
Anti-CD63 and Anti-CD44 in HIV-1-Infected MDM from Different
Donors
(A–C) Labeling densities of CD63 over different membranes as
deﬁned in Figure 6, including MDM from two additional donors 2
and 3 (corresponding to the same donors 2 and 3 as in Figure 4). The
labeling density for CD63 on the plasma membrane and limiting
vacuolar membrane are similar (if not identical) for all three donors,
whereas the labeling density on LEs is signiﬁcantly higher. Values
represent the average from two independent labeling experiments
and two different grids per experiment. Error bars denote standard
error.
(D) Remaining infectivity in supernatants of HIV-infected MDM after
virus immunoprecipitation with anti-CD63 or anti-CD44 as described
in Figure 6C. Results are shown for MDM from donors 1 and 3
(corresponding to those named equally in Figures 4, 6, and A–C of
Figure S2), for a third independent donor (donor 80), and
commercially available HIV-1, strain Ba-L, derived from a multi-
donor pool of MDM. Each virus was immunoprecipitated in
triplicate. Error bars denote standard deviation.
Found at doi:10.1371/journal.ppat.0030036.sg002 (1.5 MB TIF).
Accession Numbers
The accession numbers for the entities discussed in this study are
from the Swiss-Prot database (http://www.expasy.org/sprot). They
include Swiss-Prot entry name CD44_HUMAN, protein name
CD44 antigen, gene name CD44, LHR (P16070); Swiss-Prot entry
name CD63_HUMAN, protein name CD63 antigen, gene name
CD63, MLA1, TSPAN30 (P08962); Swiss-Prot entry name CD81_HU-
MAN, protein name CD81 antigen, gene name CD81, TAPA1,
TSPAN28 (P60033); Swiss-Prot entry name CD82_HUMAN, protein
name CD82 antigen, gene name CD82, KAI1, SAR2, TSPAN27
(P27701); and Swiss-Prot entry name LAMP1_HUMAN, protein
name lysosome-associated membrane glycoprotein 1, gene name
LAMP1 (P11279).
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